Viral Hepatit Dergisi-Viral Hepatitis Journal

Scope & Guideline

Championing the future of hepatitis research.

Introduction

Delve into the academic richness of Viral Hepatit Dergisi-Viral Hepatitis Journal with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1307-9441
PublisherGALENOS PUBL HOUSE
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationVIRAL HEPAT DERG / VIRAL HEPAT. DERG.
Frequency3 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressKacamak Sokak 21/1, ISTANBUL, Findikzade 34093, TURKIYE

Aims and Scopes

Viral Hepatitis Journal focuses on advancing the understanding and management of viral hepatitis through rigorous research and clinical studies. The journal encompasses a wide range of topics, methodologies, and patient demographics, aiming to provide a comprehensive resource for clinicians and researchers in the field.
  1. Clinical Management of Viral Hepatitis:
    The journal emphasizes studies that explore the clinical management and treatment efficacy of various antiviral therapies for hepatitis B, C, and E, including real-world data and case reports.
  2. Epidemiology and Seroprevalence Studies:
    A significant focus is placed on understanding the epidemiology of viral hepatitis, including seroprevalence studies across different populations and risk groups, such as refugees and healthcare workers.
  3. Innovative Diagnostic Tools and Technologies:
    Research on new diagnostic methodologies, including the application of artificial intelligence and non-invasive techniques for liver disease assessment, is a key area of exploration.
  4. Hepatitis Coinfections and Comorbidities:
    The journal investigates the implications of hepatitis coinfection with HIV and other viruses, as well as the impact of comorbid conditions like diabetes on hepatitis outcomes.
  5. Public Health and Access to Treatment:
    Public health initiatives, barriers to treatment access, and vaccination programs are critical themes, reflecting the journal's commitment to improving health outcomes on a broader scale.
Recent publications in the Viral Hepatitis Journal indicate a notable shift toward emerging themes and trends that reflect current challenges and advancements in the field of viral hepatitis research.
  1. Real-World Data and Treatment Outcomes:
    There is an increasing emphasis on real-world data concerning treatment outcomes and patient responses to antiviral therapies, underscoring the importance of practical evidence in clinical decision-making.
  2. Artificial Intelligence in Hepatitis Management:
    The integration of artificial intelligence for improving diagnosis and management of viral hepatitis represents a cutting-edge trend that is gaining traction within the journal's publications.
  3. Impact of COVID-19 on Hepatitis Care:
    The exploration of how the COVID-19 pandemic has affected hepatitis management and treatment access highlights an emerging theme that is critical for understanding the broader implications of global health crises.
  4. Genetic and Molecular Research:
    An increasing number of studies focusing on genetic factors, such as polymorphisms affecting treatment responses, indicate a growing trend towards personalized medicine in hepatitis treatment.
  5. Non-Invasive Assessment Techniques:
    Research into non-invasive methods for assessing liver health and fibrosis is on the rise, reflecting advancements in technology and the need for more patient-friendly diagnostic options.

Declining or Waning

While the journal has maintained a robust focus on various aspects of viral hepatitis, certain themes have shown a decline in prominence over recent years, indicating shifts in research priorities or emerging areas of interest.
  1. Traditional Treatment Methods:
    Research focusing on older treatment regimens, such as pegylated interferon therapies, has decreased as newer direct-acting antiviral agents gain prominence due to their increased efficacy and safety.
  2. Animal Models in Hepatitis Research:
    There appears to be a reduction in studies utilizing animal models for hepatitis research, possibly due to a growing emphasis on human clinical data and real-world evidence.
  3. General Hepatitis A Research:
    Research specifically targeting hepatitis A has become less frequent, suggesting a possible shift in focus to more pressing issues related to hepatitis B, C, and E.

Similar Journals

International Journal of Hepatology

Empowering global knowledge in liver health.
Publisher: HINDAWI LTDISSN: 2090-3448Frequency: 1 issue/year

The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.

JOURNAL OF CLINICAL VIROLOGY

Leading the Charge in Virology Research and Treatment
Publisher: ELSEVIERISSN: 1386-6532Frequency: 12 issues/year

Journal of Clinical Virology, published by Elsevier, stands at the forefront of virology research, focusing on the clinical implications of viral diseases. With an impressive impact factor representative of its Q1 categorization in both Infectious Diseases and Virology, this journal is essential for researchers and healthcare professionals aiming to keep pace with evolving knowledge and treatments in virology. Since its inception in 1998, it has provided a vital platform for the dissemination of significant breakthroughs, now continuing through to 2024. The journal boasts competitive Scopus ranks, placing it in the 95th percentile for Infectious Diseases and the 91st percentile for Virology. Scholars can benefit from its selective Open Access options, promoting widespread access to cutting-edge research. With an ever-increasing demand for innovative solutions to viral infections, Journal of Clinical Virology remains dedicated to fostering advancements in the field, making it a key resource for anyone invested in virology and infectious disease management.

Clinical Gastroenterology and Hepatology

Advancing the Frontiers of Gastroenterology and Hepatology
Publisher: ELSEVIER SCIENCE INCISSN: 1542-3565Frequency: 12 issues/year

Clinical Gastroenterology and Hepatology, published by Elsevier Science Inc, stands as a leading journal in the fields of gastroenterology and hepatology. With an ISSN of 1542-3565 and an E-ISSN of 1542-7714, this esteemed publication has earned its place in the top quartile (Q1) of both gastroenterology and hepatology categories as of 2023, ranking 6th out of 167 and 7th out of 82 respectively. The journal aims to disseminate innovative research, clinical studies, and case reports that advance the understanding and treatment of gastrointestinal and liver diseases. Targeted towards researchers, healthcare professionals, and students, it provides crucial insights into emerging therapies and medical advancements. Clinical Gastroenterology and Hepatology is not only a pivotal resource for contemporary gastroenterological research but also fosters collaboration and knowledge-sharing within the medical community. With a converging publication history from 2003 to the present, the journal continues to build on its solid foundation of scientific excellence and relevance.

Saudi Journal of Gastroenterology

Elevating standards in gastrointestinal research and practice.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1319-3767Frequency: 6 issues/year

The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.

INTERVIROLOGY

Exploring the frontiers of infectious disease science.
Publisher: KARGERISSN: 0300-5526Frequency: 6 issues/year

INTERVIROLOGY is a leading academic journal dedicated to advancing the field of virology and infectious diseases, published by KARGER. With a commendable history since its inception in 1973, the journal is currently poised to explore innovative virological research through to 2024. INTERVIROLOGY is indexed with the ISSN 0300-5526 and E-ISSN 1423-0100, reflecting its commitment to maintaining high scholarly standards. The journal is categorized within the Q3 quartile for both Infectious Diseases and Virology as of 2023, demonstrating its relevance and contribution to the academic community. With Scopus rankings placing it as #130 in Infectious Diseases and #41 in Virology, INTERVIROLOGY serves as an essential resource for researchers, professionals, and students seeking cutting-edge insights and discoveries in virology. While it currently operates under a subscription model, its rigorous peer-review process ensures a high quality of published content, making it a cornerstone for those dedicated to understanding and combating viral diseases.

JOURNAL OF VIRAL HEPATITIS

Enhancing understanding of viral hepatitis dynamics.
Publisher: WILEYISSN: 1352-0504Frequency: 12 issues/year

The JOURNAL OF VIRAL HEPATITIS, published by WILEY, is a leading international journal dedicated to the dissemination of cutting-edge research in the fields of hepatology, infectious diseases, and virology. Established in 1994, this esteemed journal has created a significant impact within the scientific community, reflected by its ranking in the Q1 category for infectious diseases and Q2 for both hepatology and virology in the most recent quartile rankings. The journal provides an essential platform for scholars and practitioners to share their findings on viral hepatitis, enhancing our understanding of its pathogenesis, epidemiology, and treatment options. With its impact factor reflecting a robust citation record, the JOURNAL OF VIRAL HEPATITIS remains indispensable for those engaged in research and clinical practice regarding viral hepatitic infections. Researchers can access the journal through traditional subscription routes, underlining its commitment to advancing knowledge and fostering collaboration among scientists worldwide. As it approaches its convergence with new findings and innovative methodologies by 2024, the journal looks forward to continuing its pivotal role in shaping the future of hepatology research.

Journal of Clinical and Experimental Hepatology

Transforming insights into impactful liver care.
Publisher: ELSEVIER - DIVISION REED ELSEVIER INDIA PVT LTDISSN: 0973-6883Frequency: 4 issues/year

The Journal of Clinical and Experimental Hepatology, published by Elsevier - Division Reed Elsevier India Pvt Ltd, is a premier platform dedicated to advancing the field of hepatology. With an ISSN of 0973-6883 and an E-ISSN of 2213-3453, this journal has gained recognition for its impactful contributions to both clinical practice and scientific research in the domain of liver health. Ranking in the Q2 quartile for Hepatology in 2023 and positioned at 33rd out of 82 in Scopus’s Hepatology category, it reflects a robust impact factor and a commitment to publishing high-quality, peer-reviewed articles. Researchers, clinicians, and students can engage with a wealth of open-access content covering the latest advancements, challenges, and insights in hepatology, as the journal aims to disseminate knowledge from 2011 through 2025. Join the community of experts as we explore critical developments in the understanding and treatment of liver diseases.

AIDS Research and Therapy

Fostering collaboration to combat HIV/AIDS.
Publisher: BMCISSN: 1742-6405Frequency: 1 issue/year

AIDS Research and Therapy is a prestigious peer-reviewed journal dedicated to disseminating cutting-edge research in the fields of AIDS and HIV therapy. Published by BMC, this Open Access journal has been freely available since its inception in 2004, facilitating global access to vital research findings. Based in the United Kingdom, the journal covers a diverse range of topics including molecular medicine, pharmacology, and virology, making it a crucial resource for researchers and clinicians alike. Recognized for its strong impact within the scientific community, it holds a Q2 quartile ranking in multiple categories as of 2023, including Molecular Medicine and Pharmacology. With an aim to enhance understanding and improve clinical outcomes for those affected by HIV/AIDS, AIDS Research and Therapy serves as an essential platform for the exchange of innovative ideas and practices that can inform future therapies and interventions. Researchers, professionals, and students seeking high-quality, peer-reviewed content will find this journal invaluable in advancing their knowledge and efforts in combating the HIV/AIDS epidemic.

Journal of Virus Eradication

Catalyzing breakthroughs in epidemiology and immunology.
Publisher: MEDISCRIPT LTDISSN: 2055-6640Frequency: 4 issues/year

Welcome to the Journal of Virus Eradication, a premier publication dedicated to advancing the field of virology and infectious disease research. Published by MEDISCRIPT LTD, this journal provides a vital platform for sharing cutting-edge research findings in key areas including epidemiology, immunology, and public health. With an impressive classification of Q2 in Epidemiology and Infectious Diseases for 2023, this journal exemplifies a commitment to high-quality scholarship and impactful research. The Journal of Virus Eradication is instrumental in disseminating knowledge that tackles viral threats, contributing to global health initiatives aimed at virus containment and eradication. Researchers, professionals, and students alike will find this journal an invaluable resource, making significant contributions to the scientific community and society at large.

Gastroenterologia y Hepatologia

Fostering innovation in the diagnosis and treatment of liver diseases.
Publisher: ELSEVIER ESPANA SLUISSN: 0210-5705Frequency: 10 issues/year

Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.